(Q44738351)

English

Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Judith Del Campo

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Madelene Lindqvist

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Maribel Cuello

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Malin Bäckström

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Osmir Cabrerra

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Josefine Persson

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Oliver Perez

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Ali M Harandi

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

27 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1193-1200

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Protective immunity against HSV-2 in the mouse vagina

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Recent progress in herpes simplex virus immunobiology and vaccine research

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Herpes simplex virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Nanoparticles and microparticles as vaccine-delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

New vaccines require potent adjuvants like AFPL1 and AFCo1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

TLR signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

B cell intrinsic MyD88 signals drive IFN-gamma production from T cells and control switching to IgG2c

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.035

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.11.035

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44738351&oldid=2035636284"